.Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B06A_OtherHematologicalAgents.B06AC06_Berotralstat.Berotralstat .Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B06A_OtherHematologicalAgents.B06AC06_Berotralstat.Berotralstat| name: | Berotralstat | |
| ATC code: | B06AC06 | |
| route: | oral | |
| compartments: | 2 | |
| dosage: | 150 | mg |
| volume of distribution: | 495 | L |
| clearance: | 170 | L/h |
| other parameters in model implementation | ||
Berotralstat is an oral, once-daily, small-molecule inhibitor of plasma kallikrein, used for the prophylaxis of hereditary angioedema (HAE) attacks. It is approved for use in several countries including the US and EU.
Pharmacokinetics in healthy adult subjects and patients with hereditary angioedema following daily oral administration.